Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Gelmini

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 3, 2024
External validation of COMPASS and BIOSCOPE prognostic scores in colorectal peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)Marco Tonello, Dario Baratti, Paolo Sammartino, et al.
Future Oncology (London, England)|July 6, 2022
Statins increase pathological response in locally advanced rectal cancer treated with chemoradiation: a multicenter experienceFrancesco Caputo, Chiara Santini, Andrea Casadei-Gardini, et al.
Journal of Clinical Medicine|September 23, 2022
Development and Multicenter Validation of a Novel Immune-Inflammation-Based Nomogram to Predict Survival in Western Resectable Gastric and Gastroesophageal Junction Adenocarcinoma (GEA): The NOMOGASTMassimiliano Salati, Nicola De Ruvo, Mariano Cesare Giglio, et al.
Updates in Surgery|July 5, 2022
Clinical outcomes of patients with complicated post-operative course after gastrectomy for cancer: a GIRCG study using the GASTRODATA registryGian Luca Baiocchi, Simone Giacopuzzi, Giovanni Vittimberga, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 6, 2024
Enhanced recovery after surgery (ERAS) implementation in cytoreductive surgery (CRS) and hyperthermic IntraPEritoneal chemotherapy (HIPEC): Insights from Italian peritoneal surface malignancies expert centersManuela Robella, Marco Vaira, Luca Ansaloni, et al.
British Journal of Haematology|December 20, 2015
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivationFabio Forghieri, Mario Luppi, Patrizia Barozzi, et al.
JAMA Surgery|November 27, 2024
Prophylactic Drain Placement and Postoperative Invasive Procedures After Gastrectomy: The Abdominal Drain After Gastrectomy (ADIGE) Randomized Clinical TrialJacopo Weindelmayer, Valentina Mengardo, Filippo Ascari, et al.
Annals of Surgical Oncology|November 16, 2021
Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)Marco Tonello, Dario Baratti, Paolo Sammartino, et al.
Annals of Surgical Oncology|April 6, 2022
Correction: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)Marco Tonello, Dario Baratti, Paolo Sammartino, et al.
Annals of Surgical Oncology|October 13, 2023
Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity-Score AnalysisMarco Tonello, Dario Baratti, Paolo Sammartino, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 3, 2024
External validation of COMPASS and BIOSCOPE prognostic scores in colorectal peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)Marco Tonello, Dario Baratti, Paolo Sammartino, et al.
Future Oncology (London, England)|July 6, 2022
Statins increase pathological response in locally advanced rectal cancer treated with chemoradiation: a multicenter experienceFrancesco Caputo, Chiara Santini, Andrea Casadei-Gardini, et al.
Journal of Clinical Medicine|September 23, 2022
Development and Multicenter Validation of a Novel Immune-Inflammation-Based Nomogram to Predict Survival in Western Resectable Gastric and Gastroesophageal Junction Adenocarcinoma (GEA): The NOMOGASTMassimiliano Salati, Nicola De Ruvo, Mariano Cesare Giglio, et al.
Updates in Surgery|July 5, 2022
Clinical outcomes of patients with complicated post-operative course after gastrectomy for cancer: a GIRCG study using the GASTRODATA registryGian Luca Baiocchi, Simone Giacopuzzi, Giovanni Vittimberga, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 6, 2024
Enhanced recovery after surgery (ERAS) implementation in cytoreductive surgery (CRS) and hyperthermic IntraPEritoneal chemotherapy (HIPEC): Insights from Italian peritoneal surface malignancies expert centersManuela Robella, Marco Vaira, Luca Ansaloni, et al.
British Journal of Haematology|December 20, 2015
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivationFabio Forghieri, Mario Luppi, Patrizia Barozzi, et al.
JAMA Surgery|November 27, 2024
Prophylactic Drain Placement and Postoperative Invasive Procedures After Gastrectomy: The Abdominal Drain After Gastrectomy (ADIGE) Randomized Clinical TrialJacopo Weindelmayer, Valentina Mengardo, Filippo Ascari, et al.
Annals of Surgical Oncology|November 16, 2021
Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)Marco Tonello, Dario Baratti, Paolo Sammartino, et al.
Annals of Surgical Oncology|April 6, 2022
Correction: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)Marco Tonello, Dario Baratti, Paolo Sammartino, et al.
Annals of Surgical Oncology|October 13, 2023
Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity-Score AnalysisMarco Tonello, Dario Baratti, Paolo Sammartino, et al.
Pageof 8